Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
MedTech
FDA panel votes against J&J shunt implant for heart failure
Johnson & Johnson’s billion-dollar bet on a novel implant for heart failure hit a roadblock this week.
Conor Hale
Dec 5, 2025 4:31pm
Analyst deems Janux's stock spiral an 'overreaction'
Dec 2, 2025 11:14am
J&J MedTech bolsters stroke R&D programs in Ireland
Nov 24, 2025 2:20pm
J&J's anti-tau antibody posdinemab flops in phase 2
Nov 24, 2025 9:40am
Contineum-J&J drug fails to improve vision in phase 2 MS trial
Nov 20, 2025 5:26pm
J&J pays $3B cash for Halda's cancer cell death tech
Nov 17, 2025 10:19am
